[... ] there are no criteria by which an individual could be classified as being insulin sensitive or resistant or as having mild, moderate, or severe impairment of insulin secretion. For insulin, despite the efforts of the previous workgroup (7), little progress was sustained following that group's report to stimulate enhanced harmonization among both commercial and research assays. [... ] substantial work remained to bring all clinical and research assays into harmony with one another.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados